Abstract | OBJECTIVE: METHODS: The clinical data of 32 lymphoma patients on PEG-asp-based chemotherapy from January 2008 to March 2012 were retrospectively collected and analyzed. RESULTS: CONCLUSION: PEG-asp is both effective and safe in the treatment of lymphoma and it is well-tolerated.
|
Authors | Ling-yan Ping, Wen Zheng, Xiao-pei Wang, Yan Xie, Ning-jing Lin, Mei-feng Tu, Zhi-tao Ying, Chen Zhang, Wei-ping Liu, Li-juan Deng, Jun Zhu, Yu-qin Song |
Journal | Zhonghua yi xue za zhi
(Zhonghua Yi Xue Za Zhi)
Vol. 92
Issue 46
Pg. 3257-60
(Dec 11 2012)
ISSN: 0376-2491 [Print] China |
PMID | 23328509
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Asparaginase
(administration & dosage, adverse effects)
- Female
- Humans
- Lymphoma
(drug therapy)
- Male
- Middle Aged
- Retrospective Studies
- Treatment Outcome
- Young Adult
|